COLUMBIA, Md., June 1 /PRNewswire-FirstCall/ -- Martek
Biosciences Corporation (Nasdaq: MATK) announced today that it will
be presenting at the Jefferies & Company Global Life Sciences
Conference scheduled to take place June
8-11, 2010 in New York
City. Steve Dubin, Chief Executive Officer, and
Peter L. Buzy, Chief Financial
Officer, are scheduled to present on June
10 at 3:00 p.m. Eastern
Time.
A live audio webcast of Martek's presentation can be accessed
at:
http://www.wsw.com/webcast/jeff46/matk/
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the
innovation, development, production and sales of high-value
products from microbial sources that promote health and wellness
through nutrition. The company is the world's leading provider of
algal DHA omega-3 with its flagship product, life'sDHA(TM), a
sustainable and vegetarian source of algal DHA omega-3 important
for brain, heart and eye health throughout life, for use in foods,
beverages, infant formula, and supplements. The company also
produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid,
for use in infant formula and growing up milks. Additionally,
Martek's subsidiary, Amerifit Brands, develops, markets and
distributes branded consumer health and wellness products in major
mass, club, drug, grocery and specialty stores and holds leading
brand positions in all of its key product categories. For more
information on Martek Biosciences, visit http://www.martek.com/ .
For a complete list of life'sDHA(TM) or life'sARA(TM) products,
visit http://www.lifesdha.com/ . For more information about
Amerifit Brands, visit www.amerifit.com .
Sections of this release contain forward-looking statements.
These statements are based upon numerous assumptions which Martek
cannot control and involve risks and uncertainties that could cause
actual results to differ. These statements should be understood in
light of the risk factors set forth in the company's filings with
the Securities and Exchange Commission, including, but not limited
to, the company's Form 10-K for the fiscal year ended October 31, 2009 and other filed reports on Form
10-K, Form 10-K/A, Form 10-Q and Form 8-K.
Contact:
|
Kyle
Stults
|
|
|
Investor
Relations
|
|
|
(410)
740-0081
|
|
|
|
SOURCE Martek Biosciences Corporation